Inadequate and delayed characterization of cutaneous reactions for US Food and Drug Administration–approved oncologic drugs from 2011–2020 leading to medication discontinuation
- Resource Type
- Short Communication
- Source
- In
Journal of the American Academy of Dermatology November 2021 85(5):1351-1352 - Subject
- Language
- ISSN
- 0190-9622